Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Chronic Limb-Threatening Ischemia (Phase 2)
Cornea (Phase 1)
Corneal Diseases (Phase 1)
Coronavirus Infections (Phase 1)
COVID-19 (Phase 2/Phase 3)
Diabetes Mellitus (Phase 1/Phase 2)
Diabetic Foot (Phase 2)
Intervertebral Disc Degeneration (Phase 2)
Ischemic Stroke (Phase 1/Phase 2)
Low Back Pain (Phase 2)
Mesenchymal Stem Cells (Phase 2)
Myocardial Ischemia (Phase 1/Phase 2)
Osteoarthritis, Knee (Phase 3)
Pulmonary Emphysema (Phase 2)
Rhinitis, Allergic (Phase 1)
Safety (Phase 1)
Stroke (Phase 1/Phase 2)
Tuberculosis, Spinal (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
